Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients

International Journal of STD and AIDS

Volumn 23, Issue 9, 2012, Pages

  Tabarsi, Payam ^a   Chitsaz, E ^a   Moradi, A ^a   Baghaei, P ^a   Farnia, P ^a   Marjani, M ^a   Shamai, M ^a   Amiri, M ^a   Nikaein, S ^a   Mansouri, D ^a   Masjedi, M ^a   Altice, F ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV AIDS; Iran; Mortality; Mycobacterium tuberculosis; TB; Treatment outcome

Indexed keywords

ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NELFINAVIR; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; SERUM ALBUMIN; ZIDOVUDINE;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BODY WEIGHT; CLINICAL ASSESSMENT; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; IRAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS TRANSMISSION;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; IRAN; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84867072242     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009093     Document Type: Article

References (21)

1. World Health Organization. Fight AIDS, Fight TB, Fight Now: TB/HIV Information Pack. Geneva; WHO, 2004
2. Stoneburner R, Laroche E, Prevots R, et al. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition. Arch Intern Med 1992;152:2033-7
3. Perriens JH, Colebunders RL, Karahunga C, et al. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with 'standard' chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 1991;144:750-5
4. Nunn P, Brindle R, Carpenter L, et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (six-month) mortality. Am Rev Respir Dis 1992;146:849-54
5. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991;324:289-94
6. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy, and survival. Am Rev Respir Dis 1987;136:570-4
7. Ackah AN, Coulibaly D, Digheu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 1995;345:607-10
8. Shafer RW, Block AB, Larkin C, et al. Predictors of survival in HIV-infected tuberculosis patients. AIDS 1996;10:269-72
9. Whalen C, Lahart C, Hom D, Simberkoff M, Ellner J, Horsburgh C. Accelerated clinical course of HIV infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35
10. Wallis R, Helfand MS, Whalen CC, et al. Immune activation allergic drug reactions, and mortality in HIV-associated pulmonary tuberculosis. Tubercle Lung Dis 1996;77:516-23
11. Walters E, Cotton MF, Rabie H, Schaaf HS, Walters LO, Marais BJ. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr 2008;8:1
12. Maruza M, de Alencar Ximenes RA, Lacerda HR. Treatment outcome and laboratory confirmation of tuberculosis diagnosis in patients with HIV/AIDS in Recife, Brazil. J Bras Pneumol 2008;34:394-403
13. Nunn P, Reid A, De Cock KM. Tuberculosis and HIV infection: The global setting. J Infect Dis 2007;196:S5-14
14. Tabarsi P, Mirsaeidi SM, Amiri M, Mansouri SD, Masjedi MR, Velayati AA. Clinical and laboratory profile of patients with tuberculosis/HIV co-infection at a national referral center: a case series. East Mediterr Health J 2008;14:283-91
15. Tabarsi P, Baghaei P, Mirsaeidi SM, et al. Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran. Saudi Med J 2008;29:148-50
16. Del Amo J, Perez-Hoyos S, Hernandez Aguado I, Diez M, Castilla J, Porter K. Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion. Acquir Immune Defic Syndr 2003;33:184-90
17. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1993;41:1-19
18. Collins KR, Quinones-Mateu ME, Toossi Z, Arts EJ. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev 2002;4:165-76
19. Sande M, Loeff M, Bennet R, et al. Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS 2004;18:1933-41
20. Whalen C, Horsburgh C, Hom D, Lahart C, Simerkoff M, Ellner J. Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS 1997;11:455-60
21. Telzak E, Chirgwin K, Nelson E, et al. Predictors for multidrug resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Int J Tuberc Lung Dis 1999;3:337-43